News and Features
AIDSinfo Live Help Provides One-on-One Help Online
Live Help is a service provided by AIDSinfo to provide the public with one-on-one help via the internet. It is staffed by health information specialists who are trained to provide answers to questions about HIV/AIDS treatment and research. They can also help individuals navigate the AIDSinfo Web site or find federally-approved sources for HIV information. They cannot offer medical advice or medical consultation.
Live Help is a confidential service. Live Help staff will know only the nickname chosen by the user when they begin the session. In addition, bilingual Live Help staff are available for those who need assistance in Spanish.
Live Help is available Monday through Friday from noon until 4pm EST.
- Visit the Live Help page
IMPAACT P1060 Study Team Reports Interim Results
"A recent, scheduled interim data and safety review of a clinical study comparing anti-HIV treatment regimens based on either nevirapine (NVP) or ritonavir-boosted lopinavir (LPV/r) has found the LPV/r-based regimen to be more effective than the NVP-based regimen in HIV-infected children who received a single dose of NVP at birth. Consequently, the study team has stopped enrolling children who received single-dose NVP at birth. In addition, the team has advised the parents and guardians of children who received single-dose NVP at birth and have been taking the NVP-based treatment regimen as part of the study to consult with their providers about the best regimen for their children."
NIH Celebrates 25 Years of the MACS Study
"The longest U.S. study of people with HIV/AIDS will be honored at a 25th anniversary commemoration on May 12, 2009, at the Carnegie Institution for Science in Washington, D.C. The Multicenter AIDS Cohort Study (MACS) has significantly contributed to the scientific understanding of HIV, AIDS and the effects of antiretroviral therapy through more than 1,000 publications, many of which have guided public health policy and the clinical care of people with HIV. MACS investigators prospectively study the natural and treated history of HIV infection in thousands of homosexual and bisexual men at sites in Baltimore, Chicago, Pittsburgh and Los Angeles."